Harold Bays
Harold Bays
Appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion as treatment for obesity in primary care [0.03%]
初级保健中对纳曲酮和安非他酮固定剂量长效组合用于肥胖治疗的合适应用
Ethan Lazarus
Ethan Lazarus
Background: Obesity is considered a chronic disease and is influenced by biological, environmental, and behavioral factors that can contribute to its progression. Although lifestyle changes are integral to treating obesit...
Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians [0.03%]
加拿大肥胖症的管理及影响：一项关于肥胖人群及其医生的真实世界调查
Jennifer Glass,Sophie Carter,Esther Artime et al.
Jennifer Glass et al.
Background: Obesity is a chronic relapsing disease associated with multiple complications. This study described real-world demographic/clinical characteristics, including obesity-related complications (ORCs), prescribing ...
Prevalence and association of MASLD in metabolically healthy young Asian Americans with obesity: A nationwide inpatient perspective (2019) [0.03%]
代谢健康且肥胖的年轻亚裔美国人中MASLD的流行率及其关联性：全国住院患者视角（2019）
Ahmad Alhomaid,Sukhjinder Chauhan,Yamini Katamreddy et al.
Ahmad Alhomaid et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide. Although the epidemiology of MASLD and its association with metabolically healthy obesity...
Cardiovascular safety of fixed-dose extended-release naltrexone/bupropion in clinical practice [0.03%]
临床实践中固定剂量的长效那可汀/安非他酮的心血管安全性
Michael Kyle,Dustin Burns,Catherine Rogers Murray et al.
Michael Kyle et al.
Background: The fixed-dose extended-release combination of naltrexone/bupropion (NB-ER) is indicated to treat overweight and obesity in adults as an adjunct to a reduced-calorie diet and increased physical activity. This ...
Prevalence of obesity according to body mass index, waist circumference, and waist-to-height ratio in Peru: A systematic review and meta-analysis [0.03%]
秘鲁根据身体质量指数、腰围和腰身高比的肥胖患病率：系统评价和荟萃分析
Luisa Erika Milagros Vásquez-Romero,Fiorella E Zuzunaga-Montoya,Joan A Loayza-Castro et al.
Luisa Erika Milagros Vásquez-Romero et al.
Introduction: Obesity is a global public health epidemic with significant health implications. However, studies on the prevalence of obesity in Peru have yielded varied results, highlighting the need for updated data to i...
Leveraging diagnosis and biometric data from the All of Us Research Program to uncover disparities in obesity diagnosis [0.03%]
利用"全民研究计划"中的诊断和生物特征数据来揭示肥胖症诊断中的差异问题
Alina Arseniev-Koehler,Ming Tai-Seale,Crystal W Cené et al.
Alina Arseniev-Koehler et al.
Background: Despite extensive efforts to standardize definitions of obesity, clinical practices of diagnosing obesity vary widely. This study examined (1) discrepancies between biometric body mass index (BMI) measures of ...
Weight and cardiometabolic effects of a novel oral shape-shifting superabsorbent hydrogel capsule: Prespecified and exploratory analysis of the Epitomee capsule RESET study [0.03%]
新型口服形状转换超强吸收性水凝胶胶囊对体重和心脏代谢的影响：Epitomee胶囊RESET研究的预定和探索性分析
H E Bays,J D Ard,P M O&#x;Neil et al.
H E Bays et al.
Background: Management of obesity potentially improves cardiometabolic risk factors in patients with metabolic syndrome (MetS). The Epitomee capsule is a non-pharmacological, biodegradable device treatment for weight redu...
Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials [0.03%]
GLP-1受体激动剂减重的疗效和安全性比较：以安慰剂对照试验为基础的模型meta分析
Haoyang Guo,Juan Yang,Jihan Huang et al.
Haoyang Guo et al.
Aim: Obesity is a global epidemic. The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for t...
Effect of resveratrol supplementation on metabolic risk markers and anthropometric parameters in individuals with obesity or overweight: A systematic review and meta-analysis of randomized controlled trials [0.03%]
补充白藜芦醇对肥胖或超重个体的代谢风险标志物和人体测量参数的影响：随机对照试验的系统评价和荟萃分析
Hafiz Shahbaz Zahoor,Adina Arshad,Muhammad Abdullah Masood et al.
Hafiz Shahbaz Zahoor et al.
Background: Obesity, a progressively widespread disease with a multifaceted etiology, affects nearly 800 million people worldwide. Recent trials suggest that resveratrol, a polyphenolic compound, can be effective for meta...